Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Austar Lifesciences Ltd. ( (HK:6118) ) has provided an update.
Austar Lifesciences Limited reported that all resolutions tabled at its annual general meeting on 22 May 2026 were approved by shareholders by poll vote. The meeting covered the receipt of audited financial statements for the year ended 31 December 2025 and a series of governance decisions, including director elections and auditor appointment.
Shareholders unanimously backed the re-election of four directors, authorised the board to set directors’ pay and confirmed Moore CPA Limited as auditor. They also renewed general mandates allowing the board to issue and repurchase shares and to extend the issuance mandate by the amount of shares bought back, reinforcing management’s flexibility in future capital management.
The approval of these mandates and governance items, all with 100% of votes cast in favour, signals solid shareholder support for the current management and strategy. It also preserves the company’s ability to adjust its capital structure and pursue funding or buyback opportunities, potentially affecting future liquidity and ownership dynamics in the market.
More about Austar Lifesciences Ltd.
Austar Lifesciences Limited is a Hong Kong-listed life sciences company incorporated in the Cayman Islands. The group operates in the healthcare and biotechnology-related sectors, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 6118.
The company’s governance structure centers on a board comprising executive and non-executive directors, supported by external auditors, and it relies on shareholder mandates for key capital management activities such as share issuance and repurchases.
Its investor base currently holds 512,582,000 issued shares, all of which were entitled to vote at the latest annual general meeting, indicating a relatively concentrated and fully participating shareholder structure.
Average Trading Volume: 206,526
Technical Sentiment Signal: Sell
Current Market Cap: HK$415.2M
For detailed information about 6118 stock, go to TipRanks’ Stock Analysis page.